Programme

The IDF Virtual Congress 2023 programme is organised across four streams:

  • Cardiovascular disease and hypertension
  • Eye and kidney
  • Foot and neuropathy
  • Diabetes in crisis

Discover the programme committee and streams

Programme at a glance

All times are Central European Time (CET). View this interactive time zone map to see the corresponding times in your area.

Monday, December 4

Tuesday, December 4 -
Thursday, December 7

10:00 - 11:30

11:30 - 11:45

11:45 - 13:15

13:15 - 13:30

13:30 - 14:30

14:30 - 14:45

14:45 - 16:15

Scientific session
IDF Diabetes Atlas

Movement break

Satellite symposia

Movement break

Scientific session

Movement break

Scientific session
IDF Diabetes Atlas

10:00 - 11:00

11:00 - 11:10

11:10 - 12:10

12:10 - 12:20

12:20 - 12:50

12:50 - 13:00

13:00 - 14:00

14:00 - 14:15

14:15 - 15:15

15:15 - 15:30

15:30 - 16:15

16:15 - 16:45

Scientific sessions

Movement break

Scientific sessions

Movement break

Meet-the-expert

Movement break

Satellite symposia

Movement break

Scientific sessions

Movement break

Poster presentation

Meet-the-expert

Monday, December 4
10:30-11:30: IDF Diabetes Atlas 10th Edition Launch - Part 1
13:00-13:15: Movement break
13:15-14:45: Celebrating 100 years of insulin
14:45-15:00: Movement break
15:00-16:15: Satellite symposium
16:15-16:30: Movement break
16:15-17:15: IDF Diabetes Atlas 10th Edition Launch - Part 2
Tuesday, 7 December
10:15-11:45: Satellite symposium
12:00-13:30: Session
13:30-13:45: Movement break
13:45-14:45: Satellite symposium
14:45-15:00: Movement break
15:00-16:30: Session
16:30-16:45: Movement break
16:45-17:15: Poster presentation
Wednesday 8 - Saturday 11 December
12:00-13:30: Session
13:30-13:45: Movement break
13:45-14:45: Satellite symposium
14:45-15:00: Movement break
15:00-16:30: Session
16:30-16:45: Movement break
16:45-17:15: Poster presentation

Types of sessions

Scientific Sessions
Symposium

Our 30+ 90 minutes symposia sessions will be an integral part of our congress and will be delivered by internationally acclaimed scientists in the field of diabetes care. They will display the latest findings in diabetes research and current issues in therapy and education. All symposia will include a live Q&A at the end of the session.

Debate

Hear from two opposing teams that will defend and refute current topics on diabetes. Don’t hesitate to share your opinion at the end of the debate.

Teaching lecture

Recognised experts will give educational lectures on specific topics. This format will combine a lecture with a question-and-answer session.

Seminar

Specific topics will be discussed accompanied by practical demonstrations, problem-solving or hands-on training sessions.

Interactive Sessions

The IDF Virtual Congress 2021 places great emphasis on networking and interactivity  and encourages participants to update their profile after logging in. This will help to connect with professionals who share similar interests. Our digital congress platform provides a great networking tool. By clicking on the Networking icon, you can connect with other participants and exchange messages through the chat tool or invite them for a chat through a video call.

Meet-the-Expert Sessions

Don’t miss the opportunity to address your questions directly to a leading expert. Our Meet-the-Expert networking sessions will be limited to a small number of participants to allow for maximum interaction with the expert on a specific topic.

Panel discussions

Participate in an interactive session encouraging discussion between groups of diverse panellists. A moderator will ask the panellists questions to start a conversation followed by an audience Q&A.

Delegate discussion groups

Spark a memorable conversation in our chat rooms and create your own group topic to trigger a fruitful discussion or join a pre-defined topic on the following subjects:

  • Do we understand and are we responding to the psychological drivers and consequences of diabetes complications?
  • Current and future challenges of Covid-19 and how the virus affects people with diabetes
  • Cardiovascular risks in diabetes across the globe: share your experience
  • What are the best strategies to improve adherence to foot self-care in people with and without active ulcers?
  • Treatment of diabetic kidney disease
Poster Sessions
E-poster gallery

The IDF Virtual Congress will provide you with the opportunity to hear about the latest research in diabetes care from a global audience of diabetes health professionals. You will have full access to 400+ posters in our e-poster gallery and will be able to view them during the event and up to 12 months after the Congress. You will be able to browse posters by keyword and have the opportunity to contact the abstract authors through our messaging system.

Oral poster presentation

Our best abstracts are selected for an oral poster presentation in our “Best Poster” sessions in the scientific programme.

Some sessions will also include an interactive polling feature to help expand your knowledge and exchange best practices.

All sessions will be broadcast live during the congress and made available available on-demand for 30 days after the congress. During the live sessions, you will be able to join a live Q&A with delegates and speakers from across the globe.

Programme highlights

Prof Abdul Basit
Global overview of the diabetic foot

Prof Abdul Basit will provide an overview of the the diabetic foot in the IDF Middle-East and North Africa Region, highlighting the importance of the multidisciplinary team in reducing amputation rates.

Dr. Søren Lund Kristensen
Heart failure and diabetes: diagnosis and phenotypes

Dr. Søren Lund Kristensen will discuss the risk and clinical presentation of heart failure in people with diabetes and how this differs from heart failure in people without diabetes, in terms of management and prognosis.

Prof. Juliana Chan
The variability in the trajectory of diabetic kidney disease

Prof. Juliana Chan will discuss the importance of regular assessment, quality care and new technologies in dramatically changing the outcome of diabetic kidney disease.

Karen Jones
Autonomic neuropathy

Prof. Karen Jones will discuss the clinical diagnosis and management of gastrointestinal autonomic neuropathy.

V Mohan
COVID-19 and Diabetes: The Indian Experience – Prevention and clinical management

Dr. V. Mohan will provide a broad overview of the relationship between COVID-19 and diabetes in India, the health outcomes resulting from the virus and the importance of prevention and management in reducing the severity of COVID-19 in people with diabetes.

Prof Mark Cooper
Why do some individuals with diabetes develop kidney disease?

Prof Mark Cooper will discuss the multi-omics approaches that are increasingly being examined to identify and monitor the progression of diabetic kidney disease in people living with diabetes.

Prof Paul J Thornalley
Management of somatic neuropathy

Prof Paul Thornalley will describe the evidence of abnormally low levels of vitamins in clinical diabetic neuropathy and the effect of vitamin supplements.

David Preiss
Targeting high triglycerides in diabetes: when and how?

Prof David Preiss will discuss the promise of future therapies which substantially lower triglycerides, including those working through the lipoprotein lipase pathway.

Dr Amelia Lake
Psychosocial aspects of diabetes complications

Dr Amelia Lake will introduce brief, opportunistic, health behaviour change conversations to promote uptake of screening in primary care and improve diabetes-related outcomes.

Wasim Akram
My diabetes story and the things that made a difference for me

Pakistan cricket legend Wasim Akram will share his journey with type 1 diabetes.

Anoop Misra
Therapeutic challenges for people with diabetes
Prof. Anoop Misra will discuss the use of non-insulin blood glucose lowering drugs in people with type 2 diabetes and COVID-19.
Bianca Rocca
Should aspirin be reserved for secondary prevention in type 2 diabetes?
Prof. Bianca Rocca and Prof. Jane Armitage will debate whether aspirin should be reserved for secondary prevention in type 2 diabetes.
Kamlesh Kunti
Current clinical management updates for COVID-19 and diabetes
Prof. Kamlesh Khunti will report on the epidemiology of type 2 diabetes & Covid-19 and describe the methods of improving care for people with diabetes during the pandemic.
Edgar Peters
Practical approach to antibiotic choice for infected ulcers

Dr. Edgar Peters will discuss the diagnosis and management of foot ulcers and provide an overview of the practical approach to antibiotic choice for infected ulcers.

Dr. Vijay Viswanathan
Diagnosis and management of foot ulcers

Dr. Vijay Viswanathan will discuss the simple methods that can be used by physicians to make a proper diagnosis of diabetes-related foot ulcers and their risk factors.

Prof. Solomon Tesfaye
Smart technology and new methodology in neuropathy and foot problems

Prof Solomon Tesfaye will present the “one-stop shop” screening for neuropathy and high risk foot.

Prof. Neil Reeves
Mobile apps for detection and diagnosis of foot problems

Prof Neil Reeves will discuss how artificial intelligence can be used to automatically detect diabetic foot ulcers and related pathologies.

Prof Kazem Rahimi
Hypertension – Updates

Prof Kazem Rahimi will present new insights into blood pressure lowering and cardiovascular risk reduction.

Stela Prgomelja
Diabetes complications: the experiences of people with diabetes and the health professionals who manage them

Stela Prgomelja will share her story of developing and living with a kidney complication of diabetes.

Prof. Noemi Lois
Diagnosis and surgical management of sight-threatening diabetic eye diseases

Prof Noemi Lois will review the complications of diabetic retinopathy and discuss why, despite advances in diabetic retinopathy screening, people still lose sight as a result of the condition.

Prof. Nikolaus Marx
Risk prediction and coronary artery disease in diabetes

Prof Nikolaus Marx will discuss if there is a true distinction between primary and secondary prevention in diabetes.

Rufino Silva
Diabetic eye and other complications of diabetes

Prof. Rufino Silva will discuss biomarkers to detect progression of diabetic eye disease.

Continuing Medical Education

The IDF Virtual Congress 2021 has been accredited with 18 hours of CME credits from the European Accreditation Council for Continuing Medical Education (EACCME). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).

CME certificates will be available for participants after the Congress.

Share on facebook
Share
Share on twitter
Share
Share on linkedin
Share